Medicines labeled for the same conditions
Alternatives to carteolol
18 other medicines are given the same way (ophthalmic) and in the same FDA class as carteolol or labeled mainly for the same use (glaucoma); 5 are in its class, beta-adrenergic blockers: timolol, dorzolamide and timolol, brimonidine and timolol, betaxolol and 1 more; the others include 4 prostaglandin analogs, 3 carbonic anhydrase inhibitors and 2 rho kinase inhibitors (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.774 per mL (Timolol maleate 0.5% eye drops) (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as carteolol?
Glaucoma lists all 20 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (ophthalmic) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Carteololbeta-adrenergic blocker | this medicine | 1 labeler | $1.63 per mL 1% eye drops | No | No current entry |
| Timololbeta-adrenergic blocker · same class | Glaucoma | 21 labelers | $0.774 per mL 0.5% eye drops | No | No current entry |
| Dorzolamide and timololcarbonic anhydrase inhibitor · same class | Glaucoma | 14 labelers | $0.893 per mL Dorzolamide-timolol eye drops | No | No current entry |
| Brimonidine and timololbeta-adrenergic blocker · same class | Glaucoma | 14 labelers | $2.15 per mL 0.2%-0.5% | No | No current entry |
| Betaxololbeta-adrenergic blocker · same class | Glaucoma | none listed | $8.97 per mL 0.5% eye drop | No | No current entry |
| Levobunololbeta-adrenergic blocker · same class | Glaucoma | 1 labeler | $2.82 per mL 0.5% eye drops | No | No current entry |
| Brimonidinealpha-adrenergic agonist | Glaucoma | 12 labelers | $9.06 per mL 0.1% drop | No | No current entry |
| Bimatoprostprostaglandin analog | Glaucoma | 13 labelers | $6.97 per mL 0.03% eye drops | No | No current entry |
| Latanoprostprostaglandin analog | Glaucoma | 14 labelers | $1.58 per mL 0.005% eye drops | No | No current entry |
| Travoprostprostaglandin analog | Glaucoma | 11 labelers | $9.07 per mL 0.004% eye drop | No | A presentation being discontinued |
| Dorzolamidecarbonic anhydrase inhibitor | Glaucoma | 14 labelers | $0.835 per mL 2% eye drops | No | No current entry |
| Pilocarpinecholinergic receptor agonist | Glaucoma | 2 labelers | $2.81 per mL 2% eye drops | No | A presentation being discontinued |
| Brinzolamidecarbonic anhydrase inhibitor | Glaucoma | 4 labelers | $9.00 per mL 1% eye drops | No | No current entry |
| Tafluprostprostaglandin analog | Glaucoma | 3 labelers | $2.45 per unit 0.0015% eye drop | No | No current entry |
| Latanoprostene bunod | Glaucoma | 1 labeler | $102.27 per mL 0.024% eye solution | No | No current entry |
| Brimonidine and brinzolamidecarbonic anhydrase inhibitor | Glaucoma | none listed | $26.04 per mL 1%-0.2% eye drop | No | No current entry |
| Latanoprost and netarsudilrho kinase inhibitor | Glaucoma | none listed | $139.40 per mL 0.02%-0.005% eye drp | No | No current entry |
| Netarsudilrho kinase inhibitor | Glaucoma | none listed | $131.68 per mL 0.02% eye solution | No | No current entry |
| Omidenepag isopropylprostaglandin e2 receptor agonist | Glaucoma | none listed | n/a | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Carteolol: the full record
- label, generics, price, shortages, recalls